BMC Medicine

official impact factor 5.75

Open Access Highly Access Research article

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

Heart Protection Study Collaborative Group

BMC Medicine 2005, 3:6 doi:10.1186/1741-7015-3-6

Accesses  

  • Last 30 days: 82 accesses
  • Last 365 days: 950 accesses
  • All time: 33247 accesses

Cited by

BioMed Central: 1 citation